Samheiti: Somatotropin release–inhibiting hormone (SRIH), Growth hormone–inhibiting hormone (GHIH), fP-Somatostatin, (Hluti af fP-Peptidscreening),
Sýnataka, geymsla og sýnasending
Undirbúningur: Sjúklingur þarf að vera fastandi.
Sýnaglas kælt fyrir blóðtöku og sýni skal sett STRAX í ísvatn að lokinni blóðtöku.
Gerð sýnis : EDTA-plasma.
Sýni tekið í glas (inniheldur EDTA) með fjólubláum tappa án gels (svört miðja) .
Magn: 3 mL
Geymsla sýnis: Frystir. Verður að vera komið í frysti 30 mínútum eftir blóðtöku!
Sýnasending: Þurríssending til útlanda.
Heiti tilvísunarannsóknastofu og heimilisfang
Postadress
Kliniskt kemiska laboratoriet
L 700 Provinlämningen / LabMedicin
Karolinska Universitetssjukhuset,Solna
171 76 Stockholm
Tfn: 08-517 724 26
Fax: 08-517 730 10 |
Somatostatin er einnig mælt hjá Hammersmith í London og er þá hluti af Gut hormónum (sjá skjal 517 GUT-hormón)
Heimildir
Somatostatin, fP-
Klinisk kemi
Rapportnamn: | fP-Somatostatin |
Indikationer / kompletterande analyser: | Endokrina pankreastumörer.
Kompletterande analys: fP-Kromogranin A och fP-Peptidscreening. |
Metod: | Immunkemi (RIA), radioaktivitet |
Remiss: | Klinisk kemi
Special
Ingår även i fP-Peptidscreening. |
Provtagning: | EDTA-rör, lila propp.
Minst 2 mL blod krävs.
Fasteprov
Om fler peptider beställs samtidigt, lägg till 2 mL per komponent.
För fullständig peptidscreening, se fP-Peptidscreening.
Ange provtagningstid.
Prov tas i iskylt rör och transporteras i isbad till Klinisk kemi inom 30 minuter.
Prov som tas utanför Karolinska, se förvaring. |
Förvaring / transport: | Transporteras i isbad till Klinisk kemi inom 30 minuter. Vid längre tids förvaring kylcentrifugeras provet och minst 1 mL plasma pipetteras av och fryses omgående. Skickas som frysprov.
Kylcentrifug finns på samtliga sjukhuslaboratorier men kontrollera att närvårdslaboratoriet har kylcentrifug om patienten ska provtas utanför sjukhus. |
Referensintervall: | Enhet: pmol/L
< 16 |
Svarsrutiner: | Analys utförs en gång per månad. |
Fróðleikur:
Somatostatin affects several areas of the body. In the hypothalamus, it regulates the secretion of hormones coming from the pituitary gland, including growth hormone and thyroid stimulating hormone. In the pancreas, somatostatin inhibits the secretion of pancreatic hormones, including glucagon and insulin. Finally, in the gastrointestinal tract, the hormone reduces gastric secretion and the emission of gastrointestinal hormones, such as secretin and gastrin.
Because it is an inhibitor, somatostatin is important to balance hormone levels in the body and stop the effects of over-production of certain hormones. That means that somatostatin levels that are too low can cause the problems associated with high levels of other hormones. Growth hormone, in particular, can be problematic. However, this is a rarely reported condition.
Instead, some patients will struggle with excessive somatostatin levels when they have a specific type of endocrine tumor called a somatostatinoma. This tumor produces the hormone independently. The end result is extreme suppression of the hormones normally inhibited by somatostatin, such as insulin, which can cause major health problems.
http://www.karolinska.se/KUL/Alla-anvisningar/Anvisning/9273, http://www.karolinska.se/KUL/Alla-anvisningar/Anvisning/9235